Stocktoria

Compass Therapeutics, Inc. CMPX

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-11-13

Compass Therapeutics, Inc. statistics & valuation

Market cap$374.6M
P / B2.6×

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019201920202020202120222023202420252026
Operating margin (%)
-6661.80% 2019201920202020202120222023202420252026
Return on equity (%)
-308.40% -73.90% -58.70% -21.60% -28.60% -39.40% -33.80% 2019201920202020202120222023202420252026
Shares outstanding
5.0M 7.0M 5.0M 51.2M 100.8M 126.3M 127.7M 137.8M 178.3M 180.1M 2019201920202020202120222023202420252026
Net debt ($)
-$16.0M -$45.2M -$144.5M 2019201920202020202120222023202420252026
Share buybacks ($)
2019201920202020202120222023202420252026
Return on assets (%)
-740.60% -114.40% -1000.90% -56.80% -53.40% -19.60% -27.10% -35.20% -30.30% 2019201920202020202120222023202420252026
Free cash flow margin (%)
-5282.20% 2019201920202020202120222023202420252026
Debt / equity (×)
0.82× 0.05× 0.00× 2019201920202020202120222023202420252026
EPS ($)
2019201920202020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019FY2019
Operating margin——-6661.8%———————
Net margin——-5808.8%———————
FCF margin——-5282.2%———————
Return on assets—-30.3%-35.2%-27.1%-19.6%-53.4%-56.8%-1000.9%-114.4%-740.6%
Return on equity—-33.8%-39.4%-28.6%-21.6%-58.7%-73.9%0.0%-308.4%0.0%
Debt / equity—————0.00×0.05×—0.82×—
Current ratio6.7915.0214.9619.7312.0513.844.970.032.670.06

Computed from company filings · US · as of 2026-09-30. Facts plus Stocktoria's own computed scores — not investment advice.